The Role of NAD⁺ Metabolism in Ageing

Key Takeaways

NAD⁺ is both a redox cofactor and a signaling substrate, linking energy metabolism to DNA repair, stress responses, and chromatin regulation.
Ageing is often associated with lower NAD⁺ availability, but the size and location of that decline vary by tissue, compartment, and model system.
Changes in NAD⁺ homeostasis can reflect several overlapping processes, including increased consumption by CD38 and PARPs, altered salvage-pathway flux, inflammation, and mitochondrial stress.
Evidence is strong that NAD⁺ metabolism matters in ageing biology, but weaker for any simple claim that one NAD⁺-related mechanism fully explains ageing.

What It Is

Nicotinamide adenine dinucleotide, usually written as NAD⁺, is a central metabolic cofactor. In its oxidized and reduced forms, it helps shuttle electrons through core pathways such as glycolysis, the tricarboxylic acid cycle, and oxidative phosphorylation. NAD⁺ also acts as a consumed substrate for signaling enzymes including sirtuins, poly(ADP-ribose) polymerases (PARPs), and CD38, which means its abundance affects much more than energy transfer alone. [2] [3]

Who This Is Useful For

This page is useful for readers who keep seeing NAD⁺ described as an important ageing molecule and want the biology without the supplement framing. It is especially relevant for readers trying to understand how NAD⁺ connects metabolism, inflammation, mitochondrial function, DNA repair, and circadian regulation within the broader hallmarks of ageing.

How NAD⁺ Homeostasis Works

Cells maintain NAD⁺ through several biosynthetic routes, but in mammals the salvage pathway that recycles nicotinamide back into NAD⁺ is especially important. NAMPT is a major rate-limiting enzyme in that pathway, and downstream NMNAT enzymes help generate distinct subcellular NAD⁺ pools. This matters because nuclear, cytosolic, and mitochondrial demands are not identical. [2] [9]

NAD⁺ metabolism is also tied to timekeeping and nutrient state. In mice, NAMPT expression and NAD⁺ levels oscillate with the circadian clock, helping connect cellular energy state to transcriptional regulation. [4]

Why Ageing Changes NAD⁺ Metabolism

Ageing biology creates several pressures that can lower available NAD⁺. DNA damage can drive PARP activity, chronic inflammation can increase expression of the NAD-degrading ectoenzyme CD38, and broader metabolic stress can alter salvage-pathway efficiency and compartment balance. Rather than one isolated cause, the literature points to a shift in NAD⁺ homeostasis produced by increased demand, increased consumption, and context-dependent changes in synthesis or recycling. [2] [5] [6] [7]

NAD⁺ Pathways at a Glance

Domain	Age-Relevant Change	Why It Matters	Main Caveat
Salvage synthesis	Recycling of nicotinamide through NAMPT and NMNAT enzymes can become less robust under stress	Supports ongoing NAD⁺ supply for metabolism and signaling	Effects are tissue-specific and not identical across species or life stages
PARP consumption	DNA damage can increase NAD⁺ use for repair signaling	Can divert NAD⁺ away from other pathways during persistent stress	PARP activation can be adaptive, not merely harmful
CD38 activity	CD38 expression often rises with age and inflammatory signaling	Promotes extracellular and tissue NAD⁺ breakdown	Magnitude varies by tissue and immune context
Mitochondrial pools	Subcellular NAD⁺ pools can become harder to maintain under chronic depletion	Mitochondria are especially sensitive because NAD⁺ availability affects respiration and stress signaling	Total cellular NAD⁺ does not always reveal which compartment is under strain

Links to Mitochondria, DNA Repair, and Inflammation

NAD⁺ metabolism sits at the intersection of several ageing-relevant systems. Sirtuins use NAD⁺ to regulate transcription, stress responses, and mitochondrial adaptation, while PARPs consume NAD⁺ during DNA damage responses. CD38 adds an immune and inflammatory dimension by degrading NAD⁺ and related metabolites. Because these enzymes compete for the same metabolic currency, persistent stress in one area can affect capacity elsewhere. [2] [3] [5] [6]

In ageing mice, declining NAD⁺ has been linked to impaired nuclear-mitochondrial signaling and a pseudohypoxic state, while human skin data associate increasing DNA damage and PARP activity with lower tissue NAD⁺. These findings help explain why NAD⁺ metabolism is often discussed alongside mitochondrial dysfunction, genomic maintenance, and inflammageing rather than as a stand-alone pathway. [5] [7]

Evidence from Research

Several lines of evidence support a meaningful role for NAD⁺ metabolism in ageing. Reviews and primary studies report age-associated NAD⁺ decline in multiple animal models, age-linked shifts in human plasma and skin NAD-related metabolites, and mechanistic links between NAD⁺ availability and mitochondrial or stress-response pathways. [2] [5] [7] [8]

At the same time, the evidence is not uniform across all tissues or all human datasets. A 2025 review of human clinical evidence concluded that age-related NAD⁺ decline has been consistently demonstrated in only a limited number of human studies, and that extrapolation from rodent work is not straightforward. That makes it more accurate to say that NAD⁺ dysregulation is an important part of ageing biology than to treat a generalized human NAD⁺ deficit as a settled universal fact. [10]

Compartmentation and Tissue Specificity

One reason the literature is hard to simplify is that NAD⁺ is not a single uniform pool. Nuclear, cytosolic, and mitochondrial compartments can buffer one another to some extent, but they are still biologically distinct. Recent work shows that mitochondrial NAD⁺ can act as a buffer for chronic depletion, and that functional consequences depend strongly on which compartment is affected. [9]

This compartment view also helps explain why blood, skin, liver, muscle, or brain measurements do not automatically tell the same story. NAD⁺ metabolism should therefore be interpreted as a tissue- and context-sensitive node within ageing, not as a perfectly synchronized whole-body meter. [2] [9] [10]

Evidence Quality and Interpretation

Confidence is strong that NAD⁺ metabolism is biologically important in ageing research. Mechanistic studies connect it to mitochondrial regulation, DNA repair, stress responses, inflammation, and circadian control, and hallmark-level reviews place these links within the wider ageing framework. [1] [2] [3]

Confidence is moderate that age-related NAD⁺ depletion is a direct driver of decline in many settings. Animal and cell studies support causal roles, but human evidence is still patchier and often tissue-limited. [5] [7] [8] [10]

The main interpretive caution is that NAD⁺ shifts can be both causes and consequences of other ageing processes. A lower NAD⁺ signal may reflect inflammation, DNA damage burden, mitochondrial dysfunction, or altered cellular composition rather than one master defect. [2] [6] [9]

What This Does Not Mean

It does not mean ageing is simply an NAD⁺ deficiency disorder.
It does not mean every tissue shows the same magnitude of NAD⁺ decline with age.
It does not mean a single blood or plasma measure fully captures intracellular or mitochondrial NAD⁺ status.
It does not mean NAD⁺-linked findings in model organisms translate directly to whole-body human ageing.

Summary

NAD⁺ metabolism is best understood as a coordinating layer within ageing biology rather than a single master switch. It links bioenergetics to repair, inflammatory signaling, circadian timing, and mitochondrial function, which is why changes in NAD⁺ homeostasis appear repeatedly across the ageing literature. The strongest conclusion is that NAD⁺ metabolism matters; the weaker and less defensible conclusion is that it alone explains ageing. [1] [2] [10]

References

López-Otín, C. et al. "Hallmarks of aging: An expanding universe." Cell (2023). https://pmc.ncbi.nlm.nih.gov/articles/PMC10809922/
Katsyuba, E., Romani, M., Hofer, D., & Auwerx, J. "NAD+ homeostasis in health and disease." Nature Metabolism (2020). https://www.nature.com/articles/s42255-019-0161-5
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. "NAD+ metabolism and its roles in cellular processes during ageing." Nature Reviews Molecular Cell Biology (2021). https://pubmed.ncbi.nlm.nih.gov/33414589/
Ramsey, K. M. et al. "Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD+ Biosynthesis." Science (2009). https://pmc.ncbi.nlm.nih.gov/articles/PMC2738420/
Gomes, A. P. et al. "Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging." Cell (2013). https://pmc.ncbi.nlm.nih.gov/articles/PMC4076149/
Camacho-Pereira, J. et al. "CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism." Cell Metabolism (2016). https://pmc.ncbi.nlm.nih.gov/articles/PMC4911708/
Massudi, H. et al. "Age-associated changes in oxidative stress and NAD+ metabolism in human tissue." PLoS ONE (2012). https://pubmed.ncbi.nlm.nih.gov/22848760/
Clement, J. et al. "The Plasma NAD+ Metabolome Is Dysregulated in 'Normal' Aging." Rejuvenation Research (2019). https://pmc.ncbi.nlm.nih.gov/articles/PMC6482912/
Høyland, L. E. et al. "Subcellular NAD+ pools are interconnected and buffered by mitochondrial NAD+." Nature Metabolism (2024). https://pubmed.ncbi.nlm.nih.gov/39702414/
Vinten, K. T. et al. "NAD+ precursor supplementation in human ageing: clinical evidence and challenges." Nature Metabolism (2025). https://www.nature.com/articles/s42255-025-01387-7

Educational Disclaimer

This content is provided for educational purposes only and does not constitute medical advice.

The Role of NAD+ Metabolism in Ageing